BRPI0907253A2 - Determinação de complexo de sflt-1:fator angiogênico - Google Patents
Determinação de complexo de sflt-1:fator angiogênicoInfo
- Publication number
- BRPI0907253A2 BRPI0907253A2 BRPI0907253-5A BRPI0907253A BRPI0907253A2 BR PI0907253 A2 BRPI0907253 A2 BR PI0907253A2 BR PI0907253 A BRPI0907253 A BR PI0907253A BR PI0907253 A2 BRPI0907253 A2 BR PI0907253A2
- Authority
- BR
- Brazil
- Prior art keywords
- sflt
- determination
- complex
- angiogenic factor
- angiogenic
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/515—Angiogenesic factors; Angiogenin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1935108P | 2008-01-07 | 2008-01-07 | |
| PCT/US2009/030340 WO2009089286A1 (en) | 2008-01-07 | 2009-01-07 | Determination of sflt-1:angiogenic factor complex |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0907253A2 true BRPI0907253A2 (pt) | 2015-07-14 |
Family
ID=40844891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0907253-5A BRPI0907253A2 (pt) | 2008-01-07 | 2009-01-07 | Determinação de complexo de sflt-1:fator angiogênico |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8835183B2 (pt) |
| EP (1) | EP2235529B1 (pt) |
| CN (1) | CN101918839A (pt) |
| BR (1) | BRPI0907253A2 (pt) |
| CA (1) | CA2711071A1 (pt) |
| RU (1) | RU2010133157A (pt) |
| WO (1) | WO2009089286A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010059952A1 (en) * | 2008-11-20 | 2010-05-27 | Perkinelmer Health Sciences, Inc. | Method for determining the risk of preeclampsia using pigf-2 and pigf-3 markers |
| US8349325B2 (en) * | 2008-12-23 | 2013-01-08 | Abbott Laboratories | Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making |
| US20120045778A1 (en) * | 2010-08-23 | 2012-02-23 | The Ohio State University Research Foundation | Elisa for haptoglobin-matrix metalloproteinase 9 complex as a diagnostic test for conditions including acute inflammation |
| US20120135425A1 (en) * | 2010-08-23 | 2012-05-31 | The Ohio State University Research Foundation | ELISA for Haptoglobin-Matrix Metalloproteinase 9 Complex as a Diagnostic Test for Conditions Including Acute Inflammation |
| BR122021026652B1 (pt) | 2011-10-17 | 2022-08-23 | F. Hoffmann-La Roche Ag | Método in vitro para diagnosticar fibrilação atrial intermitente, uso de uma troponina cardíaca e dispositivo para diagnosticar fibrilação atrial intermitente |
| EP2867670B1 (en) | 2012-06-27 | 2018-05-30 | Roche Diagnostics GmbH | MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD |
| US11307209B2 (en) | 2013-12-03 | 2022-04-19 | Cézanne S.A.S. | Method diagnosis of a prenatal disorder by selective determination of placental growth factor 2 |
| WO2015148989A1 (en) * | 2014-03-27 | 2015-10-01 | Wayne State University | Systems and methods to identify and treat subjects at risk for obstetrical complications |
| WO2017106527A1 (en) * | 2015-12-15 | 2017-06-22 | Case Western Reserve University | Epithelial cancer evaluation using beta defensin |
| MX2020002788A (es) | 2017-09-13 | 2020-09-14 | Progenity Inc | Biomarcadores de preeclampsia y sistemas y metodos relacionados. |
| WO2021113710A1 (en) * | 2019-12-04 | 2021-06-10 | Progenity, Inc. | Assessment of preeclampsia using assays for free and dissociated placental growth factor |
| EP4070113A4 (en) * | 2019-12-04 | 2023-12-20 | Biora Therapeutics, Inc. | ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2230542T3 (es) * | 1993-03-25 | 2005-05-01 | MERCK & CO., INC. | Inhibidor del factor de crecimiento celular endotelial vascular. |
| DK1297016T3 (da) * | 2000-05-12 | 2006-07-10 | Vlaams Interuniv Inst Biotech | Anvendelse af placentavækstfaktorinhibitorer til behandling af patologisk angiogenese, patologisk arteriogenese, inflammation, tumordannelse og/eller vaskulær lækage |
| ITRM20020277A1 (it) * | 2002-05-17 | 2003-11-17 | Geymonat Spa | Muteine del fattore di crescita placentare tipo 1, metodo di preparazione e loro applicazioni. |
| US7335362B2 (en) * | 2002-07-19 | 2008-02-26 | Beth Israel Deaconess Medical Center | Methods of treating pre-eclampsia or eclampsia |
| OA12890A (en) * | 2002-07-19 | 2006-10-13 | Beth Israel Hospital | Methods of diagnosing and treating pre-eclampsia or eclampsia. |
| US7435419B2 (en) * | 2002-07-19 | 2008-10-14 | Beth Israel Deaconess Medical Center | Methods of diagnosing and treating pre-eclampsia or eclampsia |
| WO2005017192A2 (en) * | 2003-08-14 | 2005-02-24 | The General Hospital Corporation | Screening for gestational disorders |
| EP1664797B1 (en) * | 2003-09-23 | 2015-11-11 | The General Hospital Corporation | Screening for preeclampsia |
| US20080045469A1 (en) * | 2004-04-16 | 2008-02-21 | Yihali Cao | Compositions and Methods for Inhibiting Angiogenesis |
| DE102004051847B4 (de) * | 2004-10-25 | 2008-09-18 | Dade Behring Marburg Gmbh | Verhältnis von PIGF und Flt-1 als prognostischer Parameter bei kardio-vaskulären Erkrankungen |
| ES2475975T3 (es) | 2004-12-21 | 2014-07-11 | Yale University | Diagnóstico de la preeclampsia |
| DE102005022047A1 (de) * | 2005-05-09 | 2006-11-30 | Dade Behring Marburg Gmbh | Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung |
| US20070111326A1 (en) * | 2005-11-14 | 2007-05-17 | Abbott Laboratories | Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia |
| US20080071151A1 (en) | 2006-06-30 | 2008-03-20 | Sogin David C | Method and Apparatus for Diagnosing Pre-eclampsia |
-
2009
- 2009-01-07 WO PCT/US2009/030340 patent/WO2009089286A1/en active Application Filing
- 2009-01-07 US US12/350,090 patent/US8835183B2/en active Active
- 2009-01-07 CN CN2009801017543A patent/CN101918839A/zh active Pending
- 2009-01-07 RU RU2010133157/15A patent/RU2010133157A/ru not_active Application Discontinuation
- 2009-01-07 EP EP09700404.8A patent/EP2235529B1/en active Active
- 2009-01-07 BR BRPI0907253-5A patent/BRPI0907253A2/pt not_active IP Right Cessation
- 2009-01-07 CA CA2711071A patent/CA2711071A1/en not_active Abandoned
-
2014
- 2014-09-12 US US14/484,869 patent/US9128099B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2711071A1 (en) | 2009-07-16 |
| EP2235529B1 (en) | 2016-12-14 |
| WO2009089286A1 (en) | 2009-07-16 |
| CN101918839A (zh) | 2010-12-15 |
| RU2010133157A (ru) | 2012-02-20 |
| US9128099B2 (en) | 2015-09-08 |
| EP2235529A4 (en) | 2011-04-27 |
| US8835183B2 (en) | 2014-09-16 |
| US20140377778A1 (en) | 2014-12-25 |
| US20090176247A1 (en) | 2009-07-09 |
| EP2235529A1 (en) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0907253A2 (pt) | Determinação de complexo de sflt-1:fator angiogênico | |
| NL300938I2 (nl) | Niraparib tosylaat of niraparib tosylaat monohydraat | |
| BRPI0922730A2 (pt) | formulação de anticorpo | |
| BRPI0915059A2 (pt) | conjunto de cateter de lavagem broncoalveolar | |
| DK2080901T3 (da) | Vindmølle-vindmålings-kompensation | |
| BRPI0908269A2 (pt) | aplicador | |
| BRPI0913945A2 (pt) | agentes anti-inflamatórios | |
| DK2837348T3 (da) | Kryokirurgiske fremgangsmåder | |
| DK2308607T3 (da) | Belægningsstruktur | |
| BR112013011457A2 (pt) | recalibração de instrumentos | |
| BRPI0920845A2 (pt) | uso de análogos de ácido heteroaromáticos contendo enxofre | |
| BRPI0906441A2 (pt) | Composição de concentrado emulsificável | |
| BRPI0909840A2 (pt) | Uso de 4-tio-2-deoxinucleosídios | |
| DK2276850T5 (da) | Irx-2-modificeret fremstillingsfremgangsmåde | |
| CU23884B1 (es) | Derivados de dibenzotiazepina | |
| DE112009003276A5 (de) | Badeeinrichtung | |
| DE102009036424A8 (de) | Endoskopisches Instrument | |
| DE202008016969U8 (de) | Chirurgieinstrument | |
| AT506244A3 (de) | Verbindungskörper | |
| FR2953176B1 (fr) | Piece de revetement | |
| IT1391776B1 (it) | Procedimento per la preparazione di dexlansoprazolo | |
| FR2937843B1 (fr) | Paravent medical | |
| ITMI20080011A1 (it) | Procedimento per la preparazione di diacereina | |
| AT10554U8 (de) | Verbindungskörper | |
| BRPI0919801A2 (pt) | revestimento ii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |